Alecnib 150 mg Capsule
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
LuciAle 150 mg Capsule
|
Lucius Pharma | Ask for Price |
Alecensa 150 mg Capsule
|
Roche | Ask for Price |
About our medical review process
Dr. Sophie Reynolds Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Description
Alecnib Alectinib 150 mg Capsule is a targeted cancer medicine used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It helps slow tumor growth and spread under oncologist supervision.
Benefits
-
Specifically targets ALK-driven lung cancer
-
Helps slow tumor growth and metastasis
-
Proven improvement in progression-free survival
-
Effective against brain metastases
-
Convenient oral dosing for long-term therapy
Indications and Usage
Alecnib Alectinib 150 mg Capsule is indicated for:
-
ALK-positive metastatic non-small cell lung cancer (NSCLC)
-
First-line treatment or after progression on previous ALK therapy
Diagnosis must be confirmed by ALK-testing, and treatment supervised by an oncologist.
How it Works
Alectinib blocks the activity of ALK (Anaplastic Lymphoma Kinase) — an abnormal protein that drives cancer growth in certain lung cancers. By inhibiting ALK signaling, it prevents cancer cells from multiplying and spreading.
Dosage & Administration
-
Usual adult dose: 600 mg per day (150 mg capsules × 4), divided into two doses
-
Take with food, at the same times daily
-
Swallow capsules whole—do not crush or open
-
Do not stop or change dose without medical guidance
-
Requires routine liver, kidney, heart rate, and blood tests
Use only under oncologist supervision.
Side Effects
Common side effects:
-
Constipation
-
Fatigue
-
Swelling in hands or feet
-
Muscle pain
-
Rash
-
Low red blood cell count
Serious side effects (seek urgent care):
-
Liver toxicity
-
Lung inflammation (pneumonitis)
-
Severe muscle damage (high CPK levels)
-
Slow heart rate
-
Severe anemia
Warning and Precaution
-
Not recommended during pregnancy or breastfeeding
-
Monitor liver function, CPK levels, heart rhythm, and lung symptoms
-
Use caution in patients with kidney or liver disease
-
Avoid driving if experiencing dizziness or vision changes
-
Inform doctor about all medications to prevent interactions
-
Report breathing difficulty, severe fatigue, jaundice, or muscle pain immediately
Related Products
-
Zyceva 100 mg Tablet
ErlotinibPrice on request
Request pricing -
Imatikast 400 mg Tablet
ImatinibPrice on request
Request pricing -
Pomalid 1 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pomalid 2 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pazonat 200 mg Tablet
PazopanibPrice on request
Request pricing -
CA Atra 10 mg Softgel Capsule
TretinoinPrice on request
Request pricing -
Sutinat 25 mg Capsule
SunitinibPrice on request
Request pricing -
Sutinat 12.5 mg Capsule
SunitinibPrice on request
Request pricing -
Spnib 100 mg Tablet
DasatinibPrice on request
Request pricing -
Azatend 100 mg Injection
AzacitidinePrice on request
Request pricing -
Tegonat 15 mg Capsule
TegafurPrice on request
Request pricing -
Bdenza 40 mg Capsule
EnzalutamidePrice on request
Request pricing
Related Reading
-
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
-
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026. n This marks an important milestone
-
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026. n Brain tumors, especially high-grade gliomas,
-
What are the 4 stages of lung cancer?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026. n Lung cancer staging is a
-
Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026. n The treatment landscape for EGFR-mutated
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import
Only logged in customers who have purchased this product may leave a review.



Reviews
Clear filtersThere are no reviews yet.